Mrv1909 11291916492D 18 17 0 0 0 0 999 V2000 4.3087 0.0000 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0 -2.5050 0.9014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2195 0.4889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2195 -0.3361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7905 0.4889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0761 0.9014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5050 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5050 -1.5736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7905 -0.3361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0761 -0.7486 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.3616 -0.3361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3616 0.4888 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.3528 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0672 0.4888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7817 0.9013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0672 -0.3361 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.7817 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4962 -0.3361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2 3 1 0 0 0 0 2 5 2 0 0 0 0 3 4 2 0 0 0 0 4 7 1 0 0 0 0 7 9 2 0 0 0 0 9 5 1 0 0 0 0 5 6 1 0 0 0 0 7 8 1 0 0 0 0 9 10 1 0 0 0 0 10 11 1 0 0 0 0 11 13 1 0 0 0 0 11 12 2 0 0 0 0 13 16 1 0 0 0 0 16 14 1 0 0 0 0 14 15 1 0 0 0 0 16 17 1 0 0 0 0 17 18 1 0 0 0 0 M END > DBSALT001508 > drugbank > Cl.CCN(CC)CC(=O)NC1=C(C)C=CC=C1C > InChI=1S/C14H22N2O.ClH/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4;/h7-9H,5-6,10H2,1-4H3,(H,15,17);1H > IYBQHJMYDGVZRY-UHFFFAOYSA-N > C14H23ClN2O > 270.8 > 270.1498911 > 2 > 41 > 27.767945514113045 > 1 > 1 > 0 > 1 > 2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide hydrochloride > 1.81 > 2.842913359666667 > -2.60 > 0 > 1 > 1 > 13.775423132503196 > 7.754504502964598 > 32.34 > 73.92960000000002 > 5 > 1 > 5.93e-01 g/l > palladium(2+) (4S,5S,14R,15R)-10-acetyl-4-(2-carboxyethyl)-15-ethyl-2-(2-methoxy-2-oxoethyl)-5,9,14,19-tetramethyl-20-[(2-sulfoethyl)carbamoyl]-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1,3(24),6,8,10,12,16(22),17,19-nonaene-21,23-diide > 1 > DBSALT001508 > Lidocaine hydrochloride anhydrous > DB00281 > Lidocaine > 73-78-9 > EC2CNF7XFP $$$$